Stock AFFY AFFYMAX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Affymax, Inc.

Equities

AFFY

US00826A1097

Biotechnology & Medical Research

Market Closed - OTC Markets
Other stock markets
 07:00:01 17/05/2024 pm IST 		5-day change 1st Jan Change
0.0008 USD +6.67% Intraday chart for Affymax, Inc. 0.00% +33.33%
2014 Affymax, Inc. Declares Special Cash Distribution, Payable on or About December 23, 2014; Appoints Jonathan M. Couchman as Class I Director, President and Chief Executive Officer CI
2014 Affymax Seeks Acquisitions CI

Business Summary

Affymax, Inc. is a biopharmaceutical company. The Company’s product OMONTYS (peginesatide) is for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent (ESA), designed to stimulate production of red blood cells. The Company has a collaboration to develop and commercialize peginesatide with Takeda Pharmaceutical Company Limited. In March 2012, the Food and Drug Administration (FDA) approved the Company’s product, OMONTYS.

Number of employees: 2

Sales per Business

USD in Million2012Weight2013Weight Delta
Collaboration
99.6 %
- - 1 99.6 % -
License and Royalty
0.4 %
- - 0 0.4 % -

Sales per region

USD in Million2012Weight2013Weight Delta
United States
100.0 %
94 100.0 % 1 100.0 % -98.55%

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 37,490,095 37,490,095 ( 100.00 %) 0 100.00 %

Shareholders

NameEquities%Valuation
Yellowstone Partners LLC
0.0207 %
7,770 0.0207 % 8 $
Manulife Investment Management Ltd.
0.008685 %
3,256 0.008685 % 3 $
Delux Capital Group LLC
0.001675 %
628 0.001675 % 1 $
Integrity Asset Management LLC
0.001600 %
600 0.001600 % 1 $
AlphaStream Portfolios, Inc.
0.000453 %
170 0.000453 % 0 $
QS Legg Mason Global Asset Allocation LLC
0.000229 %
86 0.000229 % 0 $

Company contact information

Affymax, Inc.

600 Fifth Avenue Suite 2260

10020, New York

+

http://www.affymax.com
address Affymax, Inc.(AFFY)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sales per Business

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
AFFYMAX, INC. Stock Affymax, Inc.
+33.33% 59.59T
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-0.09% 4.21TCr
LONZA GROUP AG Stock Lonza Group AG
+49.62% 4.2TCr
CELLTRION, INC. Stock Celltrion, Inc.
-4.96% 2.92TCr
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.18% 2.6TCr
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.95% 1.89TCr
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+8.61% 1.32TCr
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+24.73% 1.22TCr
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+28.31% 1.22TCr
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-6.26% 1.14TCr
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. AFFY Stock
  4. Company Affymax, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW